$0.92
▲ +1.4% Today
as of Sep 4, 16:52 ET
Last 30 days
Recent Press Releases & News
Nautilus Biotechnology Inc (NAUT) Q2 2026 Earnings Call Highlights: Strategic Shifts and ...
Nautilus Biotechnology Q2 Earnings Call Highlights
Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
Overview
52-week range
$0.65
$4.31
7% of range
Avg surprise (last 1)
+7.1%
Avg reaction (last 1)
+7.9%
100% positive
Latest IV / EM
2192%
EM ±342.6% · $3 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $-0.12 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.11 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $-0.12 | — | — | — | — | earnings |
| Tue Apr 29, 2025 | Mar/2025 | $-0.13 | $-0.14 | +7.1% | — | +7.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.13 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.14 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.15 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.13 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.13 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.12 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $-0.11 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $-15M | — | $-14M | $-15M | $-17M | — | $-16M | $-18M |
| EPS (diluted) | $-0.12 | — | $-0.11 | $-0.12 | $-0.13 | — | $-0.13 | $-0.14 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15M | $12M | $24M | $34M | $33M | $28M | $4M | $25M |
| Inventory | $300,000 | — | — | — | — | — | — | — |
| Total current assets | $99M | $106M | $134M | $151M | $142M | $133M | $144M | $171M |
| Total assets | $178M | $191M | $201M | $213M | $228M | $243M | $260M | $273M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $33M | $34M | $32M | $32M | $33M | $34M | $36M | $37M |
| Total equity | $144M | $157M | $169M | $181M | $194M | $209M | $223M | $235M |